secwatch / observer
8-K filed April 26, 2022, 7:59 PM ET ticker FLWS CIK 0001084869
leadership confidence high sentiment neutral materiality 0.50

1-800-FLOWERS appoints Thomas Hartnett as President; McCann remains CEO

1 800 FLOWERS COM INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Christopher G. McCann

President
FLWS · 1 800 FLOWERS COM INC
Effective
2022-04-25
Successor
Thomas Hartnett
Filed
April 26, 2022, 7:59 PM ET
Effective April 25, 2022, Christopher G. McCann has resigned as President of 1-800-FLOWERS.COM, Inc. (the “Company”). He will remain employed by the Company as Chief Executive Officer.
Appointed

Thomas Hartnett

President
FLWS · 1 800 FLOWERS COM INC
Effective
2022-04-25
Filed
April 26, 2022, 7:59 PM ET
Also effective April 25, 2022, the Board of Directors of the Company has appointed Thomas Hartnett to serve as President of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Christopher G. McCann resigned as President at 1 800 FLOWERS COM INC.

Action
resigned
Role
President
Exact text from the filing
Effective April 25, 2022, Christopher G. McCann has resigned as President of 1-800-FLOWERS.COM, Inc. (the “Company”). He will remain employed by the Company as Chief Executive Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Thomas Hartnett was appointed as President at 1 800 FLOWERS COM INC.

Action
appointed
Role
President
Exact text from the filing
Also effective April 25, 2022, the Board of Directors of the Company has appointed Thomas Hartnett to serve as President of the Company.
View on SEC.gov

1 800 FLOWERS COM INC filing history →

Source: SEC EDGAR
accession 0001437749-22-009718
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.